What is the Prosthetic of Choice in Rheumatic Mitral Valve Disease?
This nationwide retrospective study from Taiwan evaluates outcomes of biological versus mechanical mitral valve replacement in 1,576 patients.
This nationwide retrospective study from Taiwan evaluates outcomes of biological versus mechanical mitral valve replacement in 1,576 patients.
This retrospective, multicenter study utilizes latent class analysis on 2321 patients undergoing surgery for primary mitral valve disease, aiming to identify phenotypes with distinct long-term prognoses.
This study evaluates the five-year clinical and echocardiographic outcomes of patients with severe degenerative mitral regurgitation (MR) treated with transapical neochord implantation using the NeoChord DS 1000® device.
Results from a Japanese and a Swedish center, sourced from the international TAVI Registry, comparing 1-year post-TAVI survival and morbidity among patients with mild residual paravalvular leakage and those with no residual/trivial leakage post-implantation.
This commentary presents a sub-analysis of the CAMRA CardioLink-2 clinical trial, which investigates risk factors associated with elevated mean mitral gradients following mitral repair.
A retrospective analysis by a high-volume aortic valve repair center examines short- and mid-term outcomes of various isolated valve repair techniques on tricuspid aortic valves.
This meta-analysis evaluates outcomes from comparative studies on transcatheter mitral valve-in-valve (ViV) implantation versus reoperation for valve replacement in patients with degenerative mitral bioprostheses.
A systematic review and meta-analysis aimed at quantifying and analyzing biases in clinical trials comparing transcatheter aortic valve implantation and surgical aortic valve replacement.
Translational research on calcification patterns of bicuspid and tricuspid aortic valves and their implications in surgical and interventional treatment of aortic stenosis.
Short-term Outcomes and Mid-term Survival Analysis of the Polish AVALON Registry in Low-Risk Patients Undergoing TAVI vs. SAVR